At the same time, studies also showed that MALAT1 SNPs affected the susceptibility and progression of diseases including hepatocellular cancer, lung adenocarcinoma and pulmonary arterial hypertension [23–25]. This evidence concerns the gene MALAT1 and hepatocellular carcinoma.